Market Tracker

12/05 3:35pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

1.32
Delayed Data
As of 3:13pm ET
 +0.02 / +1.54%
Today’s Change
0.94
Today|||52-Week Range
4.27
-65.45%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close1.30
Today’s open1.30
Day’s range1.29 - 1.35
Volume57,301
Average volume (3 months)183,476
Market cap$8.6M
Dividend yield--
Data as of 3:13pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)+73.42%
Earnings growth (this year)+43.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales558.44
Price/Book0.96

Competitors

 Today’s
change
Today’s
% change
MATNMateon Therapeutics ...-0.02-5.63%
LPTNLpath Inc+0.13+4.87%
CBMXCombiMatrix Corp-0.05-2.00%
XTNTXtant Medical Holdin...-0.01-2.19%
Data as of 3:35pm ET, 12/05/2016

Financials

Next reporting dateApril 5, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$34.0K
Annual profit (last year)-$10.2M
Net profit margin-30,067.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts